Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
about
Association of Polymorphisms in the VDR, CYP17 and SRD5A2 Genes and Prostate Cancer Among Lebanese MenMolecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.Long-term toxicity of cisplatin in germ-cell tumor survivors.
P2860
Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Single-nucleotide polymorphism ...... d testicular cancer survivors.
@en
type
label
Single-nucleotide polymorphism ...... d testicular cancer survivors.
@en
prefLabel
Single-nucleotide polymorphism ...... d testicular cancer survivors.
@en
P2093
P1476
Single-nucleotide polymorphism ...... ed testicular cancer survivors
@en
P2093
Andries J Smit
Coby Meijer
D A Janneke Dijck-Brouwer
H Marike Boezen
Ido P Kema
Janine Nuver
Joop D Lefrandt
Martijn van Faassen
Nico-Derk L Westerink
P304
P356
10.1016/J.EJCA.2015.11.009
P577
2016-01-02T00:00:00Z